Friday 12 May 2017

Executive Research Director

Executive Research Director – Heptares Zurich

Heptares Therapeutics Ltd is clinical stage company using innovative techniques techniques in protein engineering and structure based drug design directed at G protein coupled receptors (GPCRs). Heptares has built an exciting pipeline of new medicines across disease areas including Alzheimer’s disease, migraine and cancer. Our ability to address highly validated, yet historically undruggable, GPCRs has also attracted multiple partners including …

via http://ift.tt/1puljGF

No comments: